News • Coronavirus research

Why the Omicron variant causes less severe disease

A new study by researchers from the University of Kent and the Goethe-University Frankfurt shows that the SARS-CoV-2 Omicron variant is less effective than Delta at blocking a cellular defence mechanism against viruses, the so-called 'interferon response'. Moreover, cell culture findings indicate that eight important Covid-19 drugs and drug candidates remain effective against Omicron.

Moreover, cell culture findings indicate that eight important Covid-19 drugs and drug candidates remain effective against Omicron. 

The researchers published their findings in the journal Cell Reports.

Our data provide encouraging evidence that the available antiviral Covid-19 drugs are also effective against Omicron

Jindrich Cinatl

The SARS-CoV-2 Omicron variant causes less severe disease than Delta although it is better at escaping immune protection by vaccinations and previous infections. The reasons for this have so far remained elusive. A new study by a research team with scientists from the University of Kent and the Goethe-University Frankfurt has now shown that Omicron variant viruses are particularly sensitive to inhibition by the so-called interferon response, an unspecific immune response that is present in all body cells. This provides the first explanation of why Covid-19 patients infected with the Omicron variant are less likely to experience severe disease.

The cell culture study also showed that Omicron viruses remain sensitive to eight of the most important antiviral drugs and drug candidates for the treatment of Covid-19. This included 

  • EIDD-1931 (active metabolite of molnupiravir), 
  • ribavirin, 
  • remdesivir, 
  • favipravir, 
  • PF-07321332 (nirmatrelvir, active ingredient of paxlovid), 
  • nafamostat, 
  • camostat, and 
  • aprotinin.

Prof Martin Michaelis, School of Bioscience, University of Kent, said: “Our study provides for the first time an explanation, why Omicron infections are less likely to cause severe disease. Obviously, Omicron can in contrast to Delta not effectively inhibit the host cell interferon immune response.“ 

Prof. Jindrich Cinatl, Institute of Medical Virology at the Goethe-University, added: “Although cell culture experiments do not exactly recapitulate the more complex situation in a patient, our data provide encouraging evidence that the available antiviral Covid-19 drugs are also effective against Omicron.“ 


Source: Goethe-University Frankfurt

25.01.2022

Read all latest stories

Related articles

Photo

News • Immunological improvement

How long is long Covid? New research hints at timeframe

New research provides cause for optimism that long Covid can resolve over time. Following people from the first wave of Covid-19, it monitored the longevity of immune abnormalities after an infection.

Photo

News • Impaired immune response

Research identifies being overweight as risk factor for Covid-19 severity

Being overweight – not just being obese – can increase Covid-19 severity. the elevated BMI creates an impaired antibody response to SARS-CoV-2 infection but not to vaccination, new research finds.

Photo

News • Sars-CoV-2 response study

How young children’s immune systems 'tame' the coronavirus

A new study found that the antibody response of infants and young children against Sars-CoV-2 deviates from that of adults in a small, but very significant way.

Related products

Subscribe to Newsletter